These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17699202)

  • 1. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
    Grantham JJ; Chapman AB; Torres VE
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):148-57. PubMed ID: 17699202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of progression in autosomal dominant polycystic kidney disease.
    Grantham JJ
    Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant polycystic kidney disease: time for a change?
    Chapman AB
    J Am Soc Nephrol; 2007 May; 18(5):1399-407. PubMed ID: 17429048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
    Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
    J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; Schrier RW
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.
    Poster D; Kistler AD; Krauer F; Blumenfeld JD; Rennert H; Weishaupt D; Wüthrich RP; Serra AL
    Am J Kidney Dis; 2009 Sep; 54(3):450-8. PubMed ID: 19515475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging progression in polycystic kidney disease.
    Perrone R
    N Engl J Med; 2006 May; 354(20):2181-3. PubMed ID: 16707757
    [No Abstract]   [Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic kidney disease: a 2011 update.
    Steinman TI
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):189-94. PubMed ID: 22274800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case for water in the treatment of polycystic kidney disease.
    Torres VE; Bankir L; Grantham JJ
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1140-50. PubMed ID: 19443627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seminal vesicle cysts and infertility in autosomal dominant polycystic kidney disease].
    Peces R; Venegas JL
    Nefrologia; 2005; 25(1):78-80. PubMed ID: 15789541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging for the prognosis of autosomal dominant polycystic kidney disease.
    Bae KT; Grantham JJ
    Nat Rev Nephrol; 2010 Feb; 6(2):96-106. PubMed ID: 20111050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.